http://jcps.bjmu.edu.cn

• 研究论文 • 上一篇    下一篇

普萘洛尔和4-羟普萘洛尔的药代-药效学研究

余细勇, 杨敏, 林曙光   

  1. 广东心血管病研究所临床药理室, 广州 510080
  • 收稿日期:1993-08-04 修回日期:1995-10-15 出版日期:1996-03-15 发布日期:1996-03-15

Pharmacokinetic-Pharmacodynamic Studies on Propra-nolol and 4-Hydroxypropranolol

Xi-Yong Yu, Minyang, Shu-Guang Lin   

  1. Division of Clinical Pharmacoiogy Guangdong Cardiovascular institute Guangzhou 510080
  • Received:1993-08-04 Revised:1995-10-15 Online:1996-03-15 Published:1996-03-15

摘要: 本文研究了20名健康志愿者口服单剂量和多剂量普萘洛尔(PPL)后原形物及其活性代谢物4-羟普萘洛尔(4-OH-P)的药代和药效动力学。结果显示单剂量给药时4-OH-P的血药浓度较高, C(m)max26.1±13.2ng/ml, AUC(m)180±69ng·h/ml, 分别为PPL0.500.73; T1/2K(m)10.2±5.7h, PPL2.4倍。PPL产生负性频率作用的药效半衰期显著长于血浆浓度半衰期(8.78±2.27 vs 4.23±1.33h, P<0.05)。表明4-OH-PPPLβ-阻滞效应中起重要作用。本文同时建立的PPL4-OH-P药代一药效学统一模型将有助于指导临床合理用药和药效学定量研究。

关键词: β-阻滞剂, 普萘洛尔, 4-羟普萘洛尔:药代动力学, 药效动力学

Abstract: The pharmacokinetic-pharmacodynamics of propranolol (PPL) and its active metabolite 4-hydroxypropranolol (4-OH-P) was studied on Chinese subjects by single or multiple oral administration. The efficiency of beta-blockade was measured as the reduction of heart rates or blood pressure in the supine and up right positions during rest or exercise period. After a single dose of 40 mg PPL, the plasma concentration of 4-OH-P was quite high, C(m)max and AUC (m) were 26.1±13.2 ng/ml and 180±69 ng.h/ml respectively, which were 50% and 73% of those of PPL. While after multiple dose administration, the plasma PPL concentration increased much greater than that in single administration and the 4-OH-P/PPL plasma level ratio fell from 0.79±0.64 at single dose to only 0.48±0.32 at steady-state. The pharmacodynamic half-life of PPL on inbibiting exercising heart-rate was much longer than the half life of drug concentration (8.78±2.27 vs 4.23±1.33 h. P<0.01).The Css 50. plasma concentration at steady-state producing 50% maximal efficacy, was 44.66±35.24ng/ml. The study showed that 4-OH-P is an important active metabolite of PPL and one of the possible factors causing the considering variations in the response to PPL in Chinese people.

Key words: Beta-blocker, Propranolol. Metabolite, 4-Hydroxypropranolol, Phannacokinetics, Pharmacodvnamics

Supporting: